TherapeuticsMD Inc (TXMD)

6.89
0.28 4.24
AMEX : Health Care
Prev Close 6.61
Open 6.60
Day Low/High 6.50 / 6.92
52 Wk Low/High 5.18 / 11.26
Volume 1.27M
Avg Volume 1.23M
Exchange AMEX
Shares Outstanding 196.49M
Market Cap 1.35B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Roundup

We used market volatility this week to close one position and add to two others.

Buying More TherapeuticsMD

The maker of women's health products could receive FDA approval for two late-stage products in the next 18 months.

Stocks Under $10 Weekly Summary

It was a busy time of earnings reports for the model portfolio, as the market rose for the sixth straight week.

Ballantyne and TherapeuticsMD Rise Off 2Q Results

We maintain our Two rating and price target on each stock.

TherapeuticsMD Announces Second Quarter 2016 Financial Results

TherapeuticsMD Announces Second Quarter 2016 Financial Results

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced its second quarter financial results for the quarter ended June 30, 2016.

Four Portfolio Names to Report Results

Ballantyne Strong, Builders FirstSource, Kratos Defense & Security and Therapeutics MD are on tap for after-hours releases.

TherapeuticsMD To Host Second Quarter Financial Results

TherapeuticsMD To Host Second Quarter Financial Results

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that it will hold a conference call and live audio webcast to discuss second quarter financial and business results on...

TherapeuticsMD Announces New Drug Application Submission For Yuvvexy™ (TX-004HR)

TherapeuticsMD Announces New Drug Application Submission For Yuvvexy™ (TX-004HR)

TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women's healthcare company, announced today that it has submitted its New Drug Application (NDA) for Yuvvexy with the U.

TherapeuticsMD Announces Filing Timeline For Yuvvexy (TX-004HR) New Drug Application

TherapeuticsMD Announces Filing Timeline For Yuvvexy (TX-004HR) New Drug Application

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, announced today that it expects that the New Drug Application (NDA) for Yuvvexy, the conditionally approved trade name for the Company's...

Stocks Under $10 Weekly Roundup

With market weakness expected to continue to linger, our model portfolio considers it a potentially good time to buy.

Stocks Under $10 Weekly Roundup

We trimmed two positions in the model portfolio this week amid overall market strength.

TherapeuticsMD Announces New Innovation In Compliance Packaging For Prenatal Vitamins

TherapeuticsMD Announces New Innovation In Compliance Packaging For Prenatal Vitamins

TherapeuticsMD, Inc. (NYSE MKT:TXMD) an innovative women's healthcare company and parent company of vitaMedMD ®, LLC ("vitaMedMD") and BocaGreenMD ®, Inc.

Stocks Under $10 Weekly Roundup

With the probability of an interest rate hike at the June FOMC of just 4% and also lingering uncertainty about rising interest rates over coming weeks and months, we remain comfortable with the model portfolio.

TherapeuticsMD To Present At Two Upcoming Investor Conferences

TherapeuticsMD To Present At Two Upcoming Investor Conferences

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that the company will participate in two upcoming investor conferences.

Stocks Under $10 Weekly Roundup

U.S. shares advanced for the week, but we did not make any trades in our model portfolio. Next week, however, a plethora of economic data will be released.

Stocks Under $10 Weekly Roundup

U.S. stocks are approaching oversold levels for the first time in over a month, leaving us comfortable with an above-average 25% cash position in our model portfolio as we search for new names to add.

TherapeuticsMD Presents Poster At ACOG 2016 With Additional Secondary Endpoint Data From Phase 3 Rejoice Trial

TherapeuticsMD Presents Poster At ACOG 2016 With Additional Secondary Endpoint Data From Phase 3 Rejoice Trial

TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women's healthcare company, presented additional secondary endpoint results from the pivotal phase 3 Rejoice Trial for its TX-004HR product candidate at the American...

Stocks Under $10 Weekly Roundup

U.S. stocks are approaching oversold levels for the first time in over a month, prompting our model portfolio to increase its position in Kratos Defense & Security.

Stocks Under $10 Weekly Roundup

More than half of the model portfolio reported earnings in a 48-hour stretch, but earnings season wraps up next week amid a quiet economic front.

Reaffirming TherapeuticsMD's Rating

Earnings disappointed, but the clinical pipeline is reassuring.

Today's Weak On High Volume Stock: TherapeuticsMD (TXMD)

Today's Weak On High Volume Stock: TherapeuticsMD (TXMD)

Trade-Ideas LLC identified TherapeuticsMD (TXMD) as a weak on high relative volume candidate

TherapeuticsMD To Present At Two Upcoming Investor Conferences

TherapeuticsMD To Present At Two Upcoming Investor Conferences

TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women's healthcare company, today announced that the company will participate in two upcoming investor conferences.

TherapeuticsMD Announces First Quarter 2016 Financial Results

TherapeuticsMD Announces First Quarter 2016 Financial Results

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced its first quarter financial results for the quarter ended March 31, 2016.

Stocks Under $10 Weekly Roundup

Several names in the model portfolio experienced increased volatility, despite U.S. stocks posting just fractional losses this week and holding near record highs.

Stocks Under $10 Weekly Roundup

With the market ticking higher this week, we used its strength to take profits in some of our portfolio companies.

TherapeuticsMD To Host First Quarter 2016 Financial Results Conference Call And Webcast May 3

TherapeuticsMD To Host First Quarter 2016 Financial Results Conference Call And Webcast May 3

TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women's healthcare company, today announced that it will hold a conference call and live audio webcast to discuss first quarter 2016 financial and business results on...

Stocks Under $10 Weekly Roundup

This week, we used the market rally to book profits in 2 holdings.

Stocks Under $10 Weekly Roundup

We made just one trade for the model portfolio this week as the market ended with a fractional loss.